Phase I/II study of high dose pomalidomide with G-CSF support and dexamethasone in patients with relapsed/refractory multiple myeloma.
Elisabet E ManasanchPreetesh JainWendy ChenOnyeka OriabureMaria BadilloLei FengZuzana BerkovaRobert Z OrlowskiMichael L WangPublished in: American journal of hematology (2020)